載入...
Possible Insufficiency of Generic Price Competition to Contain Prices for Orally Administered Anticancer Therapies
This study traces the use of the anticancer drug capecitabine through its loss of patent protection to evaluate the effect of generic pricing on the cost of oral anticancer drugs.
Na minha lista:
| 發表在: | JAMA Intern Med |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Medical Association
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5820701/ https://ncbi.nlm.nih.gov/pubmed/28892541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2017.2788 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|